Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
[Prospects for retroelement-targeted therapy of schizophrenia].
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosis.
The Effect of Ocrelizumab on Anti-JC Virus Antibody Index.
Neuronal injury and axonal degeneration: Pathologic mechanisms and findings beyond Wallerian changes.
Synthesis strategies of gold nanoclusters and their application in anti-inflammatory therapy.
The effect of progressive muscle relaxation on intimacy and sexuality in women with multiple sclerosis: A single-blinded randomized controlled trial.
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.
Quantitative Susceptibility Mapping of the Cervical Spinal Cord at 3T and Application to Multiple Sclerosis.
N-acetyl-L-leucine in Neurological Disorders: Mechanisms, Evidence, and Therapeutic Perspectives.
Adjunctive Molecular Hydrogen Capsule Therapy in Empyema Complicated by Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report.
Aggressive phenotype of multiple sclerosis, characterised by atypical initial symptoms and a fulminant clinical progression.
Accelerated Brain Aging Identifies Functional Vulnerability Beyond Chronological Age in Multiple Sclerosis.
A Comparison of the Effects of Vitamin B12 and Folic Acid on Gait Recovery and Myelination After Femoral Nerve Injury in Rats.
Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment.
#MultipleSclerosis: Artificial intelligence-based sentiment and content analysis of Tweets.
Pde4 mediates MHCII expression in oligodendroglia.
MicroRNA-Mediated Regulation of Brain Aging Hallmarks: Implications for Neurodegeneration and Neural Recovery.
Effectiveness of Blood Flow Restriction Training in Neurological Rehabilitation: A Systematic Review and Meta-analysis.
Iron dyshomeostasis in neuropsychiatric disorders.
Otilonium bromide ameliorates paclitaxel-induced peripheral neuropathy by targeting phosphatase PPM1A.
Anti-CD19 monoclonal antibody for systemic lupus erythematosus and neuromyelitis optica spectrum disorder.
Trehalase-trehalose axis in the human brain: A potential modulator of neuroprotection and neurodegeneration.
MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.
Pages
« first
‹ previous
…
964
965
966
967
968
969
970
971
972
…
next ›
last »